Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.
A grade PMID 42321916
View analysis →A grade PMID 42690647
View analysis →A grade PMID 42372741
View analysis →A grade PMID 42216567
View analysis →A grade PMID 41916649
View analysis →A grade PMID 42382416
View analysis →A grade PMID 42150584
View analysis →B grade PMID 42748428
View analysis →A grade PMID 41756844
View analysis →A grade PMID 42765973
View analysis →A grade PMID 42362103
View analysis →A grade PMID 42101908
View analysis →This nationwide South Korean observational study reports a policy-associated shift from 3D-conformal radiotherapy toward intensity-modulated radiotherapy for soft tissue sarcoma and lower mortality hazard estimates for IMRT than 3D-CRT in pediatric and non-surgical subgroups, without establishing a survival benefit.
Evidence: pediatric patients receiving IMRT had a lower reported mortality hazard estimate than those categorized with 3D-CRT (HR 3.35 versus 4.19), although the observational analysis was affected by confounding by indication and does not demonstrate a direct causal benefit. Inference: improved treatment conformality might support better outcomes or treatment tolerability in selected pediatric soft tissue sarcoma patients, but this requires pediatric-specific, adjusted comparative studies including disease characteristics, local control, toxicity, and survival.
In a single-centre retrospective cohort of 151 patients with giant cell tumour of bone, local recurrence occurred in 11.3%, pulmonary metastasis in 3.3%, and intralesional curettage was associated with better functional scores than wide resection for selected lower-limb tumours.
The reported association suggests—but does not establish—that selecting intralesional curettage for suitable lower-limb giant cell tumours may preserve function while maintaining acceptable oncological outcomes; prospective, risk-adjusted evidence, particularly in pediatric and adolescent patients, is needed before inferring comparative benefit.
In a retrospective cohort of 86 patients with Sturge-Weber syndrome or phakomatosis pigmentovascularis, glaucoma was the predominant source of visual-field loss, while neurological and radiotherapy-associated defects could mimic glaucomatous damage.
The evidence shows clinically distinguishable patterns of glaucomatous, neurological, combined, and post-radiotherapy visual-field loss; by inference, improved interpretation of serial perimetry could reduce misclassification and support better glaucoma-management decisions, but the study does not test whether this approach changes treatment or preserves vision.
In an exploratory online survey of 300 middle-school girls from Egypt, Saudi Arabia, and the United Arab Emirates, HPV and cervical-cancer prevention awareness was limited, while 65.7% reported willingness to accept free HPV vaccination.
The evidence identifies a gap between low prevention literacy and relatively high stated vaccine willingness; as an inference requiring prospective testing, culturally adapted school-linked education—potentially involving school nurses—could improve informed HPV-vaccine uptake and thereby support long-term cervical-cancer prevention.
In an exploratory observational study of childhood cancer survivors and typically developing children, individual and contextual resources were associated with cognitive and motor outcomes and brain morphometry, with particularly strong associations in the small CNS cancer subgroup.
The study provides associative—not interventional or causal—evidence supporting the hypothesis that strengthening potentially modifiable resources such as self-efficacy, optimism, parental support, or socioeconomic supports could contribute to multimodal neurodevelopmental rehabilitation after childhood cancer; prospective intervention studies are required to test benefit.
This retrospective single-centre cohort of 395 patients aged 15–39 years treated for cancer in Bern reported 84% five-year survival, 58% fertility consultation, 29% clinical-trial participation, and poorer survival among older patients and those with metastatic disease.
The evidence identifies age-, sex-, and stage-associated gaps in adolescent and young adult oncology care; it is reasonable but untested to hypothesize that targeted fertility counselling, improved trial access, and strengthened palliative-care pathways could improve care quality or outcomes.
In a retrospective cohort of 31 adults with unresectable gallbladder cancer, first-line gemcitabine plus nab-paclitaxel produced a 48.4% response rate, median progression-free survival of 8.4 months, median overall survival of 20.9 months, and conversion to surgery in 7 of 11 patients with locally advanced disease, with grade 3/4 toxicity in 35.5%.
The record provides preliminary observational evidence that gemcitabine plus nab-paclitaxel may control unresectable gallbladder cancer and enable resection in some locally advanced cases; whether it improves outcomes over standard regimens, and whether it has any role in pediatric or adolescent patients, remains untested.
This case report describes a 33-year-old woman with stage IVB mixed malignant ovarian germ cell tumor containing choriocarcinoma who achieved complete remission and 3-year progression-free survival after cytoreductive surgery and seven cycles of dose-dense, pediatric-inspired Cy-BEP-MTX chemotherapy.
The reported outcome provides preliminary evidence that intensive Cy-BEP-MTX can coincide with durable remission in an ultra-high-risk mixed ovarian germ cell tumor; it is an untested inference that dose density, methotrexate or cyclophosphamide addition, or the pediatric-inspired strategy itself improves outcomes over standard adult regimens.
In a cross-sectional cohort of 518 Chinese patients aged 7 to under 18 years receiving active cancer treatment, better perceived family functioning and family resilience were associated with fewer sleep problems, with significant indirect associations through depression and anxiety.
The study provides associative evidence that family protective factors, psychological distress, and sleep problems are linked; it supports—but does not test or establish—the hypothesis that family-focused and depression/anxiety-directed interventions could improve sleep during pediatric cancer treatment.
This single-center retrospective study of 775 bacterial bloodstream-infection episodes in 456 pediatric hemato-oncology patients found increasing gram-negative predominance, substantial antimicrobial nonsusceptibility, and higher estimated pathogen coverage with piperacillin/tazobactam plus amikacin than with piperacillin/tazobactam alone.
The reported susceptibility data support the setting-specific inference that adding amikacin to piperacillin/tazobactam could reduce initially inappropriate empiric treatment in stable pediatric oncology patients with suspected bloodstream infection; however, the study does not establish improved survival, safety, or net clinical benefit from this combination.
In a retrospective cohort of 106 at-risk children, including 40 diagnosed with acute invasive fungal rhinosinusitis, sinus CT showed 83% sensitivity, 97% specificity, and an AUC of 0.90, but missed seven cases, often involving the middle turbinate.
The evidence supports CT as a clinically useful but insufficiently sensitive diagnostic tool; by inference, maintaining nasal endoscopy when suspicion remains despite a negative CT could reduce missed or delayed AIFRS diagnosis in immunocompromised children, although improved treatment outcomes were not evaluated.
In a sex-balanced juvenile rat model, methotrexate produced memory impairments and CSF changes involving one-carbon and transsulfuration metabolites, plasmalogens, and phosphatidylcholines.
The study directly supports an association between methotrexate exposure, altered CSF metabolism, and later memory deficits in juvenile rats; it is reasonable but unproven to hypothesize that these pathways could yield biomarkers or targets for preventing methotrexate-associated cognitive toxicity.
